ReportWire

  • News
    • Breaking NewsBreaking News | ReportWire publishes the latest breaking U.S. and world news, trending topics and developing stories from around globe.
    • Bazaar NewsBazaar News | ReportWire publishes the latest breaking U.S. and world news, trending topics and developing stories from around globe.
    • Fact CheckingFact Checking | ReportWire publishes the latest breaking U.S. and world news, trending topics and developing stories from around globe.
    • GovernmentGovernment News | ReportWire publishes the latest breaking U.S. and world news, trending topics and developing stories from around globe.
    • PoliticsPolitics u0026#038; Political News | ReportWire publishes the latest breaking U.S. and world news, trending topics and developing stories from around globe.
    • US NewsUS News | ReportWire publishes the latest breaking U.S. and world news, trending topics and developing stories from around globe.
      • Local NewsLocal News | ReportWire publishes the latest breaking U.S. and world news, trending topics and developing stories from around globe.
        • New York, New York Local NewsNew York, New York Local News | ReportWire publishes the latest breaking U.S. and world news, trending topics and developing stories from around globe.
        • Los Angeles, California Local NewsLos Angeles, California Local News | ReportWire publishes the latest breaking U.S. and world news, trending topics and developing stories from around globe.
        • Chicago, Illinois Local NewsChicago, Illinois Local News | ReportWire publishes the latest breaking U.S. and world news, trending topics and developing stories from around globe.
        • Philadelphia, Pennsylvania Local NewsPhiladelphia, Pennsylvania Local News | ReportWire publishes the latest breaking U.S. and world news, trending topics and developing stories from around globe.
        • Dallas, Texas Local NewsDallas, Texas Local News | ReportWire publishes the latest breaking U.S. and world news, trending topics and developing stories from around globe.
        • Atlanta, Georgia Local NewsAtlanta, Georgia Local News | ReportWire publishes the latest breaking U.S. and world news, trending topics and developing stories from around globe.
        • Houston, Texas Local NewsHouston, Texas Local News | ReportWire publishes the latest breaking U.S. and world news, trending topics and developing stories from around globe.
        • Washington DC Local NewsWashington DC Local News | ReportWire publishes the latest breaking U.S. and world news, trending topics and developing stories from around globe.
        • Boston, Massachusetts Local NewsBoston, Massachusetts Local News| ReportWire publishes the latest breaking U.S. and world news, trending topics and developing stories from around globe.
        • San Francisco, California Local NewsSan Francisco, California Local News | ReportWire publishes the latest breaking U.S. and world news, trending topics and developing stories from around globe.
        • Phoenix, Arizona Local NewsPhoenix, Arizona Local News | ReportWire publishes the latest breaking U.S. and world news, trending topics and developing stories from around globe.
        • Seattle, Washington Local NewsSeattle, Washington Local News | ReportWire publishes the latest breaking U.S. and world news, trending topics and developing stories from around globe.
        • Tampa Bay, Florida Local NewsTampa Bay, Florida Local News | ReportWire publishes the latest breaking U.S. and world news, trending topics and developing stories from around globe.
        • Detroit, Michigan Local NewsDetroit, Michigan Local News | ReportWire publishes the latest breaking U.S. and world news, trending topics and developing stories from around globe.
        • Minneapolis, Minnesota Local NewsMinneapolis, Minnesota Local News | ReportWire publishes the latest breaking U.S. and world news, trending topics and developing stories from around globe.
        • Denver, Colorado Local NewsDenver, Colorado Local News | ReportWire publishes the latest breaking U.S. and world news, trending topics and developing stories from around globe.
        • Orlando, Florida Local NewsOrlando, Florida Local News | ReportWire publishes the latest breaking U.S. and world news, trending topics and developing stories from around globe.
        • Miami, Florida Local NewsMiami, Florida Local News | ReportWire publishes the latest breaking U.S. and world news, trending topics and developing stories from around globe.
        • Cleveland, Ohio Local NewsCleveland, Ohio Local News | ReportWire publishes the latest breaking U.S. and world news, trending topics and developing stories from around globe.
        • Sacramento, California Local NewsSacramento, California Local News | ReportWire publishes the latest breaking U.S. and world news, trending topics and developing stories from around globe.
        • Charlotte, North Carolina Local NewsCharlotte, North Carolina Local News | ReportWire publishes the latest breaking U.S. and world news, trending topics and developing stories from around globe.
        • Portland, Oregon Local NewsPortland, Oregon Local News | ReportWire publishes the latest breaking U.S. and world news, trending topics and developing stories from around globe.
        • Raleigh-Durham, North Carolina Local NewsRaleigh-Durham, North Carolina Local News | ReportWire publishes the latest breaking U.S. and world news, trending topics and developing stories from around globe.
        • St. Louis, Missouri Local NewsSt. Louis, Missouri Local News | ReportWire publishes the latest breaking U.S. and world news, trending topics and developing stories from around globe.
        • Indianapolis, Indiana Local NewsIndianapolis, Indiana Local News | ReportWire publishes the latest breaking U.S. and world news, trending topics and developing stories from around globe.
        • Pittsburg, Pennsylvania Local NewsPittsburg, Pennsylvania Local News | ReportWire publishes the latest breaking U.S. and world news, trending topics and developing stories from around globe.
        • Nashville, Tennessee Local NewsNashville, Tennessee Local News | ReportWire publishes the latest breaking U.S. and world news, trending topics and developing stories from around globe.
        • Baltimore, Maryland Local NewsBaltimore, Maryland Local News | ReportWire publishes the latest breaking U.S. and world news, trending topics and developing stories from around globe.
        • Salt Lake City, Utah Local NewsSalt Lake City, Utah Local News | ReportWire publishes the latest breaking U.S. and world news, trending topics and developing stories from around globe.
        • San Diego, California Local NewsSan Diego, California Local News | ReportWire publishes the latest breaking U.S. and world news, trending topics and developing stories from around globe.
        • San Antonio, Texas Local NewsSan Antonio, Texas Local News | ReportWire publishes the latest breaking U.S. and world news, trending topics and developing stories from around globe.
        • Columbus, Ohio Local NewsColumbus, Ohio Local News | ReportWire publishes the latest breaking U.S. and world news, trending topics and developing stories from around globe.
        • Kansas City, Missouri Local NewsKansas City, Missouri Local News | ReportWire publishes the latest breaking U.S. and world news, trending topics and developing stories from around globe.
        • Hartford, Connecticut Local NewsHartford, Connecticut Local News | ReportWire publishes the latest breaking U.S. and world news, trending topics and developing stories from around globe.
        • Austin, Texas Local NewsAustin, Texas Local News | ReportWire publishes the latest breaking U.S. and world news, trending topics and developing stories from around globe.
        • Cincinnati, Ohio Local NewsCincinnati, Ohio Local News | ReportWire publishes the latest breaking U.S. and world news, trending topics and developing stories from around globe.
        • Greenville, South Carolina Local NewsGreenville, South Carolina Local News | ReportWire publishes the latest breaking U.S. and world news, trending topics and developing stories from around globe.
        • Milwaukee, Wisconsin Local NewsMilwaukee, Wisconsin Local News | ReportWire publishes the latest breaking U.S. and world news, trending topics and developing stories from around globe.
    • World NewsWorld News | ReportWire publishes the latest breaking U.S. and world news, trending topics and developing stories from around globe.
  • SportsSports News | ReportWire publishes the latest breaking U.S. and world news, trending topics and developing stories from around globe.
  • EntertainmentEntertainment News | ReportWire publishes the latest breaking U.S. and world news, trending topics and developing stories from around globe.
    • FashionFashion | ReportWire publishes the latest breaking U.S. and world news, trending topics and developing stories from around globe.
    • GamingGaming | ReportWire publishes the latest breaking U.S. and world news, trending topics and developing stories from around globe.
    • Movie u0026amp; TV TrailersMovie u0026#038; TV Trailers | ReportWire publishes the latest breaking U.S. and world news, trending topics and developing stories from around globe.
    • MusicMusic | ReportWire publishes the latest breaking U.S. and world news, trending topics and developing stories from around globe.
    • Video GamingVideo Gaming | ReportWire publishes the latest breaking U.S. and world news, trending topics and developing stories from around globe.
  • LifestyleLifestyle | ReportWire publishes the latest breaking U.S. and world news, trending topics and developing stories from around globe.
    • CookingCooking | ReportWire publishes the latest breaking U.S. and world news, trending topics and developing stories from around globe.
    • Dating u0026amp; LoveDating u0026#038; Love | ReportWire publishes the latest breaking U.S. and world news, trending topics and developing stories from around globe.
    • EducationEducation | ReportWire publishes the latest breaking U.S. and world news, trending topics and developing stories from around globe.
    • Family u0026amp; ParentingFamily u0026#038; Parenting | ReportWire publishes the latest breaking U.S. and world news, trending topics and developing stories from around globe.
    • Home u0026amp; GardenHome u0026#038; Garden | ReportWire publishes the latest breaking U.S. and world news, trending topics and developing stories from around globe.
    • PetsPets | ReportWire publishes the latest breaking U.S. and world news, trending topics and developing stories from around globe.
    • Pop CulturePop Culture | ReportWire publishes the latest breaking U.S. and world news, trending topics and developing stories from around globe.
      • Royals NewsRoyals News | ReportWire publishes the latest breaking U.S. and world news, trending topics and developing stories from around globe.
    • Real EstateReal Estate | ReportWire publishes the latest breaking U.S. and world news, trending topics and developing stories from around globe.
    • Self HelpSelf Help | ReportWire publishes the latest breaking U.S. and world news, trending topics and developing stories from around globe.
    • TravelTravel | ReportWire publishes the latest breaking U.S. and world news, trending topics and developing stories from around globe.
  • BusinessBusiness News | ReportWire publishes the latest breaking U.S. and world news, trending topics and developing stories from around globe.
    • BankingBanking | ReportWire publishes the latest breaking U.S. and world news, trending topics and developing stories from around globe.
    • CreditCredit | ReportWire publishes the latest breaking U.S. and world news, trending topics and developing stories from around globe.
    • CryptocurrencyCryptocurrency | ReportWire publishes the latest breaking U.S. and world news, trending topics and developing stories from around globe.
    • FinanceFinancial News | ReportWire publishes the latest breaking U.S. and world news, trending topics and developing stories from around globe.
  • HealthHealth | ReportWire publishes the latest breaking U.S. and world news, trending topics and developing stories from around globe.
    • CannabisCannabis | ReportWire publishes the latest breaking U.S. and world news, trending topics and developing stories from around globe.
    • NutritionNutrition | ReportWire publishes the latest breaking U.S. and world news, trending topics and developing stories from around globe.
  • HumorHumor | ReportWire publishes the latest breaking U.S. and world news, trending topics and developing stories from around globe.
  • TechnologyTechnology News | ReportWire publishes the latest breaking U.S. and world news, trending topics and developing stories from around globe.
    • GadgetsGadgets | ReportWire publishes the latest breaking U.S. and world news, trending topics and developing stories from around globe.
  • Advertise With Us

Tag: medicines

  • Leader of Israel’s Labor: Something is ‘very wrong’ on the global left

    Leader of Israel’s Labor: Something is ‘very wrong’ on the global left

    [ad_1]

    Press play to listen to this article

    Voiced by artificial intelligence.

    MÁLAGA, Spain — The leader of Israel’s center-left Labor Party says something has gone “very wrong” with the political left around the world, with supposed progressives now aligning themselves with Islamist militants who oppose the rights of women and LGBTQ+ people.

    Over a month after Hamas militants attacked Israel, killing about 1,200 people and captured some 240, Israeli officials revised their death toll downwards as Israel wages a retaliatory war against Hamas in Gaza, which has now killed more than 11,000 Palestinians — according to the Hamas-run health ministry.

    Mass protests have been held in cities across the EU and U.S. calling for an immediate cease-fire, with many using the slogan “from the river to the sea,” regarded by many Jews and Israelis as a call for the annihilation of the state of Israel but by Palestinians and their supporters as a non-violent rallying cry against the occupation.

    At the protests and on university campuses, some protestors describing themselves as left-wing have expressed support for Hamas — proscribed as a terror organization by the U.S., EU and U.K. Tensions in the left-wing camp have already boiled over in France and Britain. The far-left France Unbowed party led by Jean-Luc Mélenchon, for example, avoids describing Hamas as terrorists and was the only major political party not to attend a rally against rising antisemitism last weekend. Meanwhile, Keir Starmer, the U.K. Labour Party leader, has been pummelled by the left of his party for refusing to call for a cease-fire.

    “I think something very bad is happening on the left,” Labor leader Merav Michaeli told POLITICO in an interview. “It became very, very clear in this attack that people who consider themselves to be democratic, progressive, are supporting a totalitarian terror regime that oppresses women [and] the LGBTQ+ community,” she said on the fringes of an international meeting of Socialist and social democrat parties in Spain.

    Some politicians on the far left have primarily blamed Israel for the the latest cycle of violence.

    “The more you go to the left, the more there’s a big mix-up. Something went very wrong on the way,” Michaeli told POLITICO, adding that Israel has some “very strong allies” on the center-left.

    “I fail to see how shouting jihad and calling for a mass murder of Jews is pro-Palestinian,” she added. “It’s important for me to emphasize to them that when you do not very strongly go against Hamas, and what it does in Gaza including to its own people, you are complicit.” 

    Israel has imposed a total siege on Gaza, allowing only a trickle of humanitarian aid into the densely-inhabited territory and obliging hundreds of thousands of Palestinians to move south to escape daily bombardments.

    Michaeli, a transport minister in the previous Israeli government, is a long-time critic of Israeli Prime Minister Netanyahu, who is leading a far-right coalition and formed a war cabinet with centrist Benny Gantz after October 7. Michaeli called during the interview for Netanyahu to “go now.”

    But she also sought to focus attention on the trauma suffered by Israeli society in the wake of the October 7 attacks.

    “When I’m speaking to people outside of Israel, then they need to understand that even the biggest peace activists and even the biggest believers in the two state solutions are now under a horrible attack,” she said.

    Protesters demand immediate ceasefire in Gaza at Place de la Republique in Brussels | John Thys/AFP via Getty Images

    Labor and its antecedent political movements dominated Israeli politics for some 30 years after the birth of the nation in 1948, with members including such prominent politicians as Yitzhak Rabin, Shimon Peres and Ehud Barak. But as Israel shifted to the right, Labor was sidelined as a political force, with now only four members – including Michaeli herself — in the 120-seat Knesset.

    “The way to rebuild Israel is to take it back,” she said, before correcting herself: “It’s not even back, it’s to put it on the Zionist democratic, liberal path.” Michaeli explained that this means pushing for a two-state solution as outlined under the Oslo accords that Rabin, her predecessor as Labor Party leader, negotiated in the 1990s.

    Cease-fire divisions

    At the meeting in Spain, calls by some national parties from countries such as France, Ireland and Belgium for a cease-fire in Gaza divided delegates and did not make it into the final agreed text. The left more broadly has been rocked by divisions over how to respond to the war in Gaza.

    Michaeli, whose party is a mere observer to the Party of European Socialists, could not directly negotiate the final text that was agreed upon in Málaga.

    But she said: “[Calling for a] cease-fire now is giving permission to Hamas to continue rearming itself, continue stealing food, water, medicine and fuel from its own people and yes, rebasing itself.” She suggested that calls for a cease-fire were being influenced by “PR” for Hamas.

    She put the blame for thousands of civilian deaths in Gaza on Hamas, rather than on the Israeli army, whose actions she defended.

    “They are dying because Hamas is using them as human shields, because they have based everything from equipment to missiles to their headquarters in the midst of the most civilian functions there are,” Michaeli said.

    She criticized what she perceived as a lack of support among EU politicians to push for the release of some 240 hostages kidnapped by Hamas. “I would have loved to hear more about that than just a mention, at least as much as they’re talking about the humanitarian needs in Gaza,” she said.

    [ad_2]

    Eddy Wax

    Source link

    November 9, 2023
  • Aid enters Gaza as Rafah border crossing opens

    Aid enters Gaza as Rafah border crossing opens

    [ad_1]

    The Egyptian-controlled Rafah border crossing from the Gaza Strip opened on Saturday morning, letting trucks carrying humanitarian aid into the blockaded enclave, which has been under siege from the Israeli military for almost two weeks.

    The first of 200 trucks loaded with about 3,000 tons of aid, which have been blocked near the Rafah crossing for days, started moving toward Gaza early Saturday, the Associated Press reported.

    Earlier this week, U.S. President Joe Biden said Egypt had agreed to open the border and let 20 trucks enter the Palestinian enclave, while Israel said it would allow the delivery of food, water or medicine — but no fuel — from Egypt, provided they were limited to civilians in the southern part of Gaza and would not go to Hamas militants.

    European leaders were quick to welcome the border’s opening. European Commission President Ursula von der Leyen said on social media that the crossing’s opening was “an important first step that will alleviate the suffering of innocent people.” German Chancellor Olaf Scholz said it was “good and important that the first humanitarian aid is now coming to the people in Gaza.”

    “They need water, food and medicine – we won’t leave them alone,” Scholz said.

    The Gaza Strip has been besieged by Israeli forces since October 9, when Israel’s Defense Minister Yoav Gallan moved to restrict all access to food, water and energy in the enclave in retaliation for a surprise incursion from the Hamas militant group that killed at least 1,400 people in Israel.

    In response, Israel launched thousands of airstrikes on Gaza, killing more than 4,100 people, according to Palestinian health authorities, and ordered all civilians to evacuate Gaza City to the southern part of the enclave as its troops get ready for a ground assault.

    The U.N. has called on Israel to reverse course, with a spokesperson saying an evacuation in Gaza “could transform what is already a tragedy into a calamitous situation.”

    The news of the border crossing’s opening comes as leaders of a dozen countries — including top officials from Germany, France, Turkey and Qatar — are set to meet in Cairo on Saturday at the invitation of Egypt’s leader Abdel Fattah el-Sisi, in an attempt to prevent the conflict from escalating into a broader regional war.

    Meanwhile, Israel asked its citizens living in neighboring Jordan and Egypt to leave those countries “as soon as possible” and to “avoid staying in all the Middle East/Arab countries,” according to a joint statement from the prime minister’s office and the foreign ministry.

    [ad_2]

    Nicolas Camut

    Source link

    October 19, 2023
  • UN warns of Gaza catastrophe as Israel prepares ground invasion

    UN warns of Gaza catastrophe as Israel prepares ground invasion

    [ad_1]

    Press play to listen to this article

    Voiced by artificial intelligence.

    The ongoing blockade of Gaza has pushed the enclave’s 2.3 million people to the brink of starvation, Cindy McCain, executive director of the U.N.’s World Food Program, warned on Sunday.

    Israel has besieged the densely populated coastal region for almost two weeks, refusing to allow in food and medical aid amid fears it could fall into the hands of the militant group Hamas. As Israel intensified airstrikes over the weekend in preparation for a ground invasion, the first 20 aid trucks entered Gaza on Saturday after being blocked near the Egyptian-controlled Rafah border crossing.

    But a lot more aid needs to be delivered, McCain told POLITICO.

    “Right now we’re facing a catastrophe in the area with the inability to feed people and the inability for the people to find anything to eat at all,” McCain said in an interview Sunday. “These people are going to starve to death unless we can get in.”

    Her warning was echoed by the regional director of the relief organization Mercy Corps, Arnaud Quemin, who told POLITICO a ceasefire is needed if there is going to be a sustainable flow of humanitarian aid into the Gaza.

    Quemin warned that a spread of the conflict to neighboring countries, like Lebanon, already wracked by recent wars and deep in an economic crisis, would present the international community with a “daunting challenge.”

    A second convoy of aid trucks entered the Egyptian side of the Rafah border crossing on Sunday, heading toward the Gaza Strip, Reuters reported, citing Egyptian security and humanitarian sources at Rafah. The trucks were carrying medical and food supplies, according to the report.

    There are already an estimated 1.5 million Syrian refugees in Lebanon and any major displacement of the Lebanese from southern Lebanon in the event of full-scale hostilities breaking out between Israel and Iran-backed Hezbollah, a Hamas ally, would have catastrophic repercussions, Quemin said on Sunday. “It would be horrible. I hope the all the major actors in the region understand that there aren’t any buffers.”

    The Gaza Strip has been besieged by Israeli forces since October 9, when Israel’s Defense Minister Yoav Gallan moved to restrict all access to food, water and energy in the enclave in retaliation for a surprise incursion from the Hamas militant group that killed at least 1,400 people in Israel.

    Israel’s retaliatory air and missile strikes have killed at least 4,385 Palestinians, including hundreds of children, and displaced more than a million people, Gaza’s health ministry said on Saturday.

    Israel intensified its airstrikes Saturday night, killing more than 50 Palestinians, according to medical authorities in Gaza. The Israeli military warned that civilians who refused to relocate to the southern part of Gaza could be identified as sympathizers with a terrorist organization, Reuters reported.

    Next stages of the war

    Israeli military officials are warning that the near-constant aerial bombardment of the coastal enclave will only intensify in the coming days in preparation for a ground incursion into the Gaza.

    “We will increase our strikes, minimize the risk to our troops in the next stages of the war, and we will intensify the strikes, starting from today,” Daniel Hagari, a spokesman for Israel Defense Forces (IDF), said on Saturday, adding that a ground operation in Gaza would be launched when conditions are right.

    All eyes are now on the next move by the IDF, which has amassed huge numbers of troops outside Gaza and pounded the densely populated area with airstrikes in its attempt to eradicate Hamas following its deadly October 7 attack on Israel.

    Meanwhile, Israel on Sunday launched an airstrike on the Al-Ansar Mosque in the city of Jenin in occupied West Bank, claiming militant Palestinian groups have been using it to plan “an imminent terror attack.” Violence has flared in the West Bank with Israel stepping up operations since the Hamas attack on southern Israel two weeks ago.

    And according to Syria’s state news agency, Israeli airstrikes targeted both Damascus and Aleppo airports in the early hours Sunday, putting out of action the runways and forcing air traffic to be diverted to the city of Latakia. An Israel Defense Forces spokesperson declined to comment.

    Israel earlier struck both airports on October 12 amid fears that Iran might use them to transfer weaponry to Hezbollah in readiness to launch a “second front” against Israel, something Iran and the Lebanese militant group have threatened to do if Israel fails to stop bombing Gaza.

    Since the Gaza war erupted earlier this month, Hezbollah and Israel have been trading fire across the southern Lebanese border with increasing intensity. Both sides have largely confined their exchanges to military targets with Hezbollah acknowledging 15 of its fighters have been killed but claiming to have knocked out two Israeli tanks.

    ‘The heart of the battle’

    Speaking at a funeral for one of the dead fighters on Sunday, a senior Hezbollah official vowed to step up attacks on Israel. Sheikh Naim Kassem, deputy leader, said Hezbollah is “already in the heart of the battle,” adding his group is “trying to weaken the Israeli enemy and let them know we are ready.” He added: “Do you [Israel] believe that if you try to crush the Palestinian resistance, other resistance fighters in the region will not act?”

    Visiting troops on Israel’s northern border on Sunday, Israeli Prime Minister Benjamin Netanyahu warned that if Hezbollah wants war, Israel is ready. Netanyahu said Hezbollah would be making “the mistake of its life.” He added: “We will strike it with a force it cannot even imagine, and the significance for it and the state of Lebanon will be devastating.”

    Hezbollah is “dragging Lebanon into a war that it will gain nothing from, but stands to lose a lot,” Israeli army spokesman Jonathan Conricus said on Sunday. “Hezbollah is playing a very, very dangerous game.”

    Lebanon’s caretaker Prime Minister Najib Mikati has admitted publicly that his government has little leverage on Hezbollah. In a phone call with the Lebanese leader on Sunday, U.S. Secretary of State Antony Blinken noted “growing concerns over rising tensions” but underscored continued American support “for Lebanon’s army, security forces and people,” according to the U.S. State Department.

    Israel’s Ministry of Defense announced Sunday that it is instructing more communities near the Lebanese border to evacuate. Twenty-eight communities were evacuated last week living within 2.8 kilometers of the border, but now the buffer zone is being expanded to 5 kilometers affecting another 14 communities. According to Mercy Corps, more than 12,000 Lebanese have been displaced by the fighting in southern Lebanon.

    For humanitarian agencies, the immediate concern is Gaza and they are lobbying for all sides to allow more aid to get through to the besieged enclave.

    “We can’t allow politics to begin to shape how humanitarian aid is given or sent in and so that’s what we’re pressing on people,” McCain said, noting the increased risk of diseases like cholera due to the collapse of Gaza’s water and sanitation services. “This is a humanitarian crisis. We need to be in there and we need to be in there now.”

    Before the blockade, about 400 aid trucks entered the territory every day. After a visit by U.S. President Joe Biden last week, Israel said it would allow deliveries of food, water and medicine — but not fuel — from Egypt, provided they were limited to civilians in the southern part of Gaza and did not go to Hamas militants.

    The 20 aid trucks that entered on Saturday “are not enough,” Samer AbdelJaber, the World Food Program’s country director for Palestine, said in a statement.

    Palestinians carry their share of food aid provided to poor families at the United Nations Relief and Works Agency for Palestine Refugees (UNRWA) distribution center | Mahmud Hams/AFP via Getty Images

    Saturday’s deliveries “are a window of hope amid a catastrophic situation,” AbdelJaber said. “But they are not enough. We need continuous access. People need food, water and medicine every day, not just once.”

    McCain said the WFP had systems in place to minimize the risk. “We have ways to be able to track and trace our goods,” she said. “We also have ways to make sure that our recipients are actually the people who should be getting it and not the bad guys.”

    Bartosz Brzezinski reported from Brussels. Jamie Dettmer reported from Beirut.

    [ad_2]

    Bartosz Brzezinski

    Source link

    October 19, 2023
  • Scientists who paved way for COVID-19 mRNA vaccines win Nobel prize

    Scientists who paved way for COVID-19 mRNA vaccines win Nobel prize

    [ad_1]

    Katalin Karikó and Drew Weissman have been awarded the Nobel prize in medicine for their work on messenger RNA technology, which enabled the development of the first vaccines against COVID-19.

    The Nobel Assembly at Sweden’s Karolinska Institute, which is responsible for selecting the winner of one of science’s most prestigious prizes, said on Monday that the discoveries “were critical for developing effective mRNA vaccines against COVID-19.”

    mRNA vaccines work by delivering into the body genetic instructions for building proteins that are present in the virus being immunized against. That spurs cells to create those proteins, which the body then recognizes as foreign and attacks; training the immune system and creating protection against the actual virus.

    In the early 1990s, Karikó, from Hungary, was working at the University of Pennsylvania looking at how mRNA could be used in medicine. She was joined in her research by U.S. colleague Weissman, an immunologist specializing in dendritic cells, which are responsible for the body’s immune response during vaccination.

    Together, the scientists discovered how to alter mRNA so that it wasn’t immediately detected by the body’s immune system and could deliver its payload to the target cells. Further work by the pair improved the efficiency of mRNA, so that it stimulated more protein production.

    “Through their discoveries that base modifications both reduced inflammatory responses and increased protein production, Karikó and Weissman had eliminated critical obstacles on the way to clinical applications of mRNA,” said the Nobel Assembly.

    As well as laying the groundwork for mRNA vaccines, Karikó was employed from 2013 to 2022 at vaccine developer BioNTech, which, together with Pfizer, produced the first COVID-19 vaccine approved in the EU.

    Pharma companies are now developing mRNA vaccines and therapies for a swathe of different diseases including flu, tuberculosis, HIV, malaria, Lyme disease, Zika and various types of cancer.

    The award comes with a cash prize of 11 million Swedish krona (€950,000). In 1951, Max Theiler won the prize for his work helping discover the vaccine against yellow fever.

    [ad_2]

    Carlo Martuscelli

    Source link

    September 28, 2023
  • Why dengue in Europe could spell disaster for the rest of the world 

    Why dengue in Europe could spell disaster for the rest of the world 

    [ad_1]

    Press play to listen to this article

    Voiced by artificial intelligence.

    In the early morning of the last day of August, Parisians experienced for the first time a practice normally confined to tropical regions — authorities fumigating the city against the tiger mosquito. The event was a tangible confirmation of what public health stats already showed: Dengue, the deadly mosquito-borne disease, had well and truly arrived in Europe. 

    In 2022, Europe saw more cases of locally acquired dengue than in the whole of the previous decade. The rise marks both a public health threat and a corresponding market opportunity for dengue vaccines and treatments; news that should spur the pharma industry to boost investment into the neglected disease. 

    On the face of it, this shift would appear to benefit not only countries like France but also nations like Bangladesh and the Philippines that have long battled dengue.

    But that assumption could be fatally flawed, experts told POLITICO. 

    People working in the field say the rise of dengue in the West could, in fact, make it harder to get lifesaving drugs to those who need them most, because pharma companies develop tools that are less effective in countries where the dengue burden is the highest or because wealthy nations end up hoarding these medicines and vaccines. 

    “It might look like a good thing — and it is a good thing — that we’re getting more products developed, but does it then create a two-tier system where high-income populations get access to it and then we still have the access gap for low- and middle- income countries?” asked Lindsay Keir, director of the science and policy advisory team at think tank Policy Cures Research.

    Killer invading mosquitoes

    Climate change and migration mean the mosquitoes that transmit dengue, as well as other diseases such as chikungunya and Zika, are setting up shop in Europe. The most recent annual data from the European Centre for Disease Prevention and Control shows that, in 2022, Europe saw 71 cases of locally acquired dengue: 65 in France and six in Spain.

    While dengue usually results in mild or no symptoms, it can also lead to high fever, severe headache and vomiting. Severe dengue can cause bleeding from the gums, abdominal pain and, in some cases, death.

    So far, the mosquito has mostly been confined to Southern Europe but it’s a worry across the Continent. In Belgium, the national public health research institute Sciensano has even launched an app where members of the public can submit photos of any Asian tiger mosquitos they spot.

    The diseases spread by these mosquitoes have traditionally fallen under the umbrella of neglected tropical diseases, a group of infections that affect mainly low-income countries and struggle to attract research and development investment. But this is changing.

    Policy Cures Research, which publishes an annual report on R&D investment into neglected diseases, removed dengue vaccines from their assessment in 2013. Dengue was no longer seen as an area where there was market failure, due to the emergence of a market that the private sector could tap into. 

    The organization is still tracking dengue drugs and biologics and their 2022 analysis showed a 33 percent increase in funding for research into non-vaccine products compared to the previous year, with industry investment reaching a record high of $28 million. 

    Climate change and migration mean the mosquitoes that transmit dengue, as well as other diseases such as chikungunya and Zika, are setting up shop in Europe | Lukas Schulze/Getty Images

    Sibilia Quilici, executive director of the vaccine maker lobby group Vaccines Europe, said the most recent pipeline review of members found that roughly 10 percent were targeting neglected diseases. There is more R&D happening in this area, said Quilici.

    Across the major drugmakers, J&J is working on a dengue antiviral treatment and MSD has a dengue vaccine in their pipeline, while Sanofi has a second yellow fever jab in development. Two dengue vaccines are already approved in the EU — one from Sanofi and another from Takeda. Moderna recently told POLITICO that it is looking closely at a dengue vaccine candidate and it already has a Zika candidate in the works. 

    For the few, not the many

    But just because there might soon be larger markets for Big Pharma doesn’t mean the products will be suitable for the populations that have been waiting years for these tools. 

    Rachael Crockett, senior policy advocacy manager at the non-profit Drugs for Neglected Diseases initiative (DNDi), said increased pharma investment in a particular disease won’t necessarily lead to products developed that are globally relevant. “Industry will — and governments are also more likely to — focus on prevention,” she said.

    That means tools such as vaccines will be prioritized; but in countries where dengue is endemic, the rainy season completely overburdens their health systems and what they desperately need are treatments, said Crockett.  

    She also said a massive increase in investment without a structure to ensure access to resulting products means “we have absolutely no guarantee that there isn’t going to be hoarding, [that] there isn’t going to be high prices.” Case in point: The U.S. national stockpile of Ebola vaccines, which exists despite there never having been an Ebola outbreak in the country.

    But just because there might soon be larger markets for Big Pharma doesn’t mean the products will be suitable for the populations that have been waiting years for these tools | Noel Celis/AFP via Getty Images

    Underlying many of these fears are the mistakes of the COVID-19 pandemic, which saw countries with less cash and political heft at the back of the queue when it came to vaccines.

    Lisa Goerlitz, head of German charity Deutsche Stiftung Weltbevölkerung (DSW)’s Brussels office, warned if drug development picks up because of a growing market in high-income countries, then accessibility, affordability and other criteria that make it suitable for low resource settings might not be prioritized.

    Vaccines Europe’s Quilici sought to allay these concerns, pointing to the pharma industry’s Berlin Declaration, a proposal to reserve an allocation of real-time production of vaccines in a health crisis. Quilici said this was a “really strong commitment …which comes right from the lessons learnt from COVID-19 and which could definitely overcome the challenges we had during the pandemic, if it is taken seriously.”

    CORRECTION: This article has been updated to correct the spelling of Lisa Goerlitz.

    [ad_2]

    Ashleigh Furlong

    Source link

    September 28, 2023
  • Beyond the pale? Why the EU is regulating breast milk

    Beyond the pale? Why the EU is regulating breast milk

    [ad_1]

    Press play to listen to this article

    Voiced by artificial intelligence.

    The European Union regulates all sorts of banks: money banks, blood banks, sperm banks. 

    Its next target? Breast milk banks.

    Brussels bureaucrats want to homogenize the rules overseeing the donation and use of donor breast milk across the bloc. 

    It’s part of the European Commission’s proposed revamp of the laws covering safety and quality standards for substances of human origin (SoHO) intended for human use. Currently, the laws cover blood, tissues and cells, but the EU wants to extend coverage to all SoHO — including donor breast milk.

    While, at first glance, it might seem like the EU is trying to milk its regulatory powers, experts are largely in favor of the plan to set EU-wide standards, saying it will improve its availability and safety.

    With lawmakers and EU countries debating the revamp, POLITICO walks you through the issue.

    What are breast milk banks?

    Women who make more breast milk than their babies need can donate it to a breast milk bank.

    These banks screen donors and collect, process and distribute the milk to infants in need — those whose mother’s own milk is not available or sufficient.

    While exclusive breastfeeding is recommended for all babies in the first six months of their life, it’s especially important for premature or sick newborns, experts say.

    Among many other benefits, breast milk contains antibodies that are important for newborns’ immune systems. Babies born before 30 weeks of pregnancy are especially susceptible to infections, particularly from necrotizing enterocolitis, a type of gut inflammation that can be fatal. Their survival rates improve when they get human milk as compared with formula, said Elien Rouw, a breastfeeding medicine specialist in Germany and president-elect of the Academy of Breastfeeding Medicine.

    There are currently 282 breast milk banks in Europe, including Turkey and Ukraine, according to the European Milk Bank Association.

    Aren’t they already regulated?

    Donor breast milk is regulated differently in different countries. For example, it’s considered a health product in France, a food in Germany, and is uncategorized and unregulated in Romania. And while the safety standards are set at the national level in France, for instance, they are set at the regional level in Belgium.

    The Commission wants to harmonize breast milk safety standards across the EU | Kenzo Tribouillard/AFP via Getty Images

    There is some level of convergence though. For example, most national guidelines in the world recommend donor breast milk should be pasteurized, according to the European Milk Bank Association.

    In France, for example, the milk is first tested for bacteria and highly contaminated milk is thrown out, explains Jean-Charles Picaud, professor of pediatrics specialized in neonatology at Hôpital de la Croix-Rousse in Lyon, and president of the French Human Milk Bank Association. The rest is then pasteurized at precisely 62.5 degrees Celsius for exactly 30 minutes and then retested before being made available for babies.

    What does the Commission want to do?

    The Commission wants to harmonize safety standards across the EU, not only to ensure the safety of the babies that consume breast milk, but also to make it easier for donor breast milk — and other SoHO — to cross borders. 

    Donor milk banks are unevenly spread out across the Continent. There are over 30 in France, for example, but only four in Belgium and one in Romania. And parts of Europe are facing a shortage of donor breast milk, while it remains in limited supply elsewhere. 

    “There are children dying in Germany because they didn’t have, or didn’t have enough, human milk,” Rouw, the breastfeeding medicine specialist in Germany, said. Centers in Germany caring for extremely premature babies without direct access to a milk bank are buying it in part from Belgium and the United States, she added.

    Experts agree that having harmonized safety standards would make the cross-border exchange of breast milk easier, improving babies’ access to it. These include things like donor selection criteria, maternal blood tests for infections, hygiene standards during collection, cold chain conditions during transport, and testing the milk for bacteria, said Picaud, president of the French Human Milk Bank Association.

    However, while the Commission is setting out the principle of bloc-wide standards in its regulation, it aims to leave it to expert bodies — the European Centre for Disease Prevention and Control (ECDC) and the European Directorate for the Quality of Medicines & HealthCare (EDQM) — to hammer out the precise scientific and technical details so that these can be more easily updated should the need arise.

    Should donors get paid?

    The debate over paying for substances of human origin is a divisive one. Germany’s Human Milk Bank Initiative, a nongovernmental organization that promotes nonprofit donor milk banks, warned in a position statement to the Commission in 2020 that “ethically questionable approaches” have been used globally to acquire human milk from “lactating mothers in resource-limited regions or from socio-economically disadvantaged populations.”

    EU countries take varying approaches when it comes to donor compensation for breast milk. Donors in France, for instance, receive no financial compensation. In Sweden, donating mothers receive a nominal 250 Swedish krona (€22.56) per liter of donated milk.

    The Commission’s proposed revision includes guidance on compensation for all SoHO donors, to allow any financial losses to be covered — but leaves it to EU countries to determine whether to allow it and if so, the conditions for it, ensuring they remain “financially neutral.”

    As well as human milk banks, the new law would also apply to any company looking to commercialize breast milk as an ingredient.

    A nurse checks reserves of breast milk in the Sant’Anna hospital in Turin, Italy | Diana Bagnoli/Getty Images

    Given the growing body of research showing the clinical benefits of donor breast milk for premature babies, hospital-affiliated milk banks around the world are expanding their activities — and there’s also growing commercial interest, a Commission spokesperson told POLITICO.

    At least one company is using breast milk to make fortifiers for sick and premature babies in the neonatal intensive care unit, which are then added to either a mother’s milk or donor milk.

    [ad_2]

    Sarah Taissir Bencharif

    Source link

    March 2, 2023
  • The EU and UK have a Northern Ireland deal — so what’s in it?

    The EU and UK have a Northern Ireland deal — so what’s in it?

    [ad_1]

    Press play to listen to this article

    Voiced by artificial intelligence.

    LONDON — After four months of intense talks (and plenty of squabbling before that), the EU and U.K. have a deal to resolve their long-running post-Brexit trade row over Northern Ireland.

    But as U.K. Prime Minister Rishi Sunak works to sell the so-called “Windsor framework” on the Northern Ireland protocol to Brexiteers and unionists, lawmakers on both sides of the English Channel and of the Irish Sea are getting to grips with the details.

    From paperwork to plants, let POLITICO walk you through the new agreement, asking: Who has given ground, and how exactly will the deal thrashed out by EU and U.K. negotiators aim to keep the bloc’s prized single market secure?

    Customs paperwork and checks

    For businesses taking part in an expanded “trusted trader scheme,” the Windsor framework aims to considerably cut customs paperwork and checks on goods moving from Great Britain but destined to stay in Northern Ireland. 

    These goods will pass through a “green lane” requiring minimal paperwork and be labeled “Not for EU,” while those heading for the EU single market in the Republic of Ireland will undergo full EU customs checks in Northern Ireland’s ports under a “red lane.”

    Traders in the green lane will only need to complete a single, digitized certificate per truck movement, rather than multiple forms per load.

    Sunak has already claimed that this means “any sense of a border in the Irish Sea” — deeply controversial among Northern Ireland’s unionist politicians — has now been “removed.”

    However, it’s by no means a total end to Irish Sea red tape. An EU official said that although the deal delivers a “dramatic reduction” in the number of physical food safety checks, for example, there will still be some — those seen as “essential” to avoid the risk of goods entering the single market.

    These checks will be based on risk assessments and intelligence, and aimed at preventing smuggling and criminality.

    U.K. public health and safety standards will meanwhile apply to all retail food and drink within the U.K. internal market. British rules on public health, marketing, organics, labeling, genetic modification, and drinks such as wines, spirits and mineral waters will apply in Northern Ireland. This will remove more than 60 EU food and drink rules in the original protocol, which were detailed in more than 1,000 pages of legislation.

    Supermarkets, wholesalers, hospitality and food producers are likely to welcome the new arrangements. Many had stopped supplying to Northern Ireland because the cost of filling out hundreds of certificates for each consignment was deemed too high for a market as small as Northern Ireland. 

    Export declarations have been removed for the vast majority of goods moving from Northern Ireland to Great Britain.

    The EU’s safeguards: While offering to drastically reduce the volume of checks carried out, the EU has toughened its criteria to become a trusted trader under the expanded scheme. The EU will now have access to databases tracking shipments of goods between Great Britain and Northern Ireland in real time. The system was tested through the winter, helping build trust in Brussels, and is being fed with data from traders and U.K. authorities. The European Commission will be able to suspend part or all of these trade easements if the U.K. fails to comply with the new rules.

    The timeline: The U.K. government said it will consult with businesses in the “coming months” before implementing the new rules. The green lane will come into force this fall. Labels for meat, meat products and minimally-processed dairy products such as fresh milk will come into force from October 1, 2024. All relevant products will be marked by July 1, 2025. “Shelf-stable” products like bread and pasta will not be labeled.

    Governance

    A key plank of the deal is the bid to address complaints by Northern Ireland’s Democratic Unionist Party (DUP) — currently boycotting the power-sharing assembly in the region in opposition to the protocol — that lawmakers there did not have a say in the imposition of new EU rules in the region.

    Under the terms of the new agreement, the Commission will have to give the U.K. government notice of future EU regulations intended to apply in Northern Ireland. According to Sunak, Stormont will be given a new power to “pull an emergency brake on changes to EU goods rules” based on “cross-community consent.”

    Under this mechanism, the U.K. government will be able to suspend the application in Northern Ireland of an incoming piece of EU law at the request of at least 30 members of the assembly — a third of them. But if unionist parties in Northern Ireland want to trigger the new “Stormont brake,” they must first return to the power-sharing institutions which they abandoned last May. The EU and the U.K. could subsequently agree to apply such a rule in a meeting of the Joint Committee, which oversees the protocol.

    Commission President Ursula von der Leyen said this new tool remains an emergency mechanism that hopefully will not need to be used. A second EU official said it would be triggered “under the most exceptional circumstances and as a matter of last resort in a well-defined process” set out in a unilateral declaration by the U.K. These include that the rules have a “significant and lasting impact on the everyday lives” of people in the region.

    If the EU disagrees with the U.K.’s trigger of the Stormont brake, the two would resolve the issue through independent arbitration, instead of involving the Court of Justice of the EU.

    Meanwhile, Northern Ireland’s courts will consider disputes over the application of EU rules in the region, and judges could decide whether to consult the CJEU on how to interpret them. In a key concession, the Commission has agreed not to unilaterally refer a case to the CJEU, although it retains the power to do so.

    The EU’s safeguards: The CJEU will remain the “sole and ultimate arbiter of EU law” and will have the “final say” on EU single market disputes, von der Leyen stressed. Whether Brexiteers and the DUP are willing to accept that remains the million-dollar question.

    Tax, state aid and EU rules

    The U.K. government will now be able to set rules in areas such as VAT and state aid that will also apply in Northern Ireland — two major wins for Sunak that were rejected by the Commission in previous rounds of negotiations with other U.K. prime ministers.

    It will, Sunak was at pains to point out Monday, allow Westminster to pass on a cut in alcohol duty that previously passed Northern Ireland by.

    But London has had to give up on its idea of establishing a dual-regulatory mechanism that would have allowed Northern Ireland businesses to choose whether they would follow EU or British rules when manufacturing goods, depending on whether they intended to sell them in the EU single market or in the U.K. The whole idea was deemed by Brussels as impossible to police.

    The EU’s safeguards: Northern Irish businesses producing goods for the U.K. internal market will only have to follow “less than 3 percent” of EU single market rules, a U.K. official said. But the nature of these regulations remains unclear, and there will be increased market surveillance and enforcement by U.K. authorities to try and reassure the EU.

    The timeline: The U.K. government will be able to exercise these powers as soon as the Windsor framework comes into force.

    Parcels

    The EU and the U.K. have agreed to scrap customs processes for parcels being sent between consumers in Great Britain to Northern Ireland.

    The EU’s safeguards: Parcels sent between businesses will now move through the new green lane, as is the case for other goods destined to stay in Northern Ireland. That should allow them to be monitored, but remove the need to undergo international customs procedures. Parcel operators will share commercial data with the U.K.’s tax authority, HMRC, in a bid to reduce risks to the EU single market.

    Timeline: These new arrangements will take effect September 2024.

    Pets

    Residents in Great Britain will be able to take their dogs, cats and ferrets to Northern Ireland without having to fulfill a requirement for a rabies vaccine, tapeworm treatment and other checks.

    Pets traveling from Northern Ireland to Great Britain and back will not be required to have any documentation, declarations, checks or health treatments.

    The EU’s safeguards: Microchipped pets will be able to travel with a life-long pet travel document issued for free by the U.K.’s Department for Environment, Food and Rural Affairs. Pet owners will tick a box in their travel booking acknowledging they accept the scheme rules and will not move their pet into the EU.

    The timeline: The new rules will take effect fall 2023.

    Medicines

    Drugs approved for use by the U.K.’s medicines regulator, the MHRA, will be automatically available in every pharmacy and hospital in Northern Ireland, “at the same time and under the same conditions” as in the U.K., von der Leyen said. 

    Businesses will need to secure approval for a U.K.-wide license from the MHRA to supply medicines to Northern Ireland, rather than having to go through the European Medicines Agency. The agreement removes any EU Falsified Medicines Directive packaging, labeling and barcode requirements for medicines. This means manufacturers will be able to produce a single medicines pack design for the whole of the U.K., including Northern Ireland.

    Drugs being shipped into Northern Ireland from Great Britain will be freed of customs paperwork, checks and duties, with traders only being required to provide ordinary commercial information.

    The EU’s safeguards: Medicines traveling from Great Britain to Northern Ireland will do so via the new green lane, which will have monitoring to protect the single market built in.

    The timeline: The U.K. government said it will engage with the medicines industry soon on these changes.

    Plants

    The deal lifts the protocol’s ban on seed potatoes entering Northern Ireland from Great Britain, and its prohibition on trees and shrubs deemed of “high risk” for the EU single market. This will enable garden centers and other businesses in Northern Ireland to sell 11 native species to Great Britain and some from other regions.

    The Windsor framework also removes sanitary and phytosanitary (SPS) checks on all these plants, and ditches red tape on their shipment into Northern Ireland.

    The EU’s safeguards: Supplying businesses will have to obtain a Northern Ireland plant health label, which will be the same as the plant passport already required within Great Britain, but with the addition of the words “for use in the U.K. only” and a QR code linking to the rules.

    The timeline: The new scheme and the lifting of the bans will all come into force in the fall.

    [ad_2]

    Cristina Gallardo

    Source link

    February 21, 2023
  • Europe is running out of medicines

    Europe is running out of medicines

    [ad_1]

    Press play to listen to this article

    Voiced by artificial intelligence.

    When you’re feeling under the weather, the last thing you want to do is trek from pharmacy to pharmacy searching for basic medicines like cough syrup and antibiotics. Yet many people across Europe — faced with a particularly harsh winter bug season — are having to do just that.

    Since late 2022, EU countries have been reporting serious problems trying to source certain important drugs, with a majority now experiencing shortages. So just how bad is the situation and, crucially, what’s being done about it? POLITICO walks you through the main points.

    How bad are the shortages?

    In a survey of groups representing pharmacies in 29 European countries, including EU members as well as Turkey, Kosovo, Norway and North Macedonia, almost a quarter of countries reported more than 600 drugs in short supply, and 20 percent reported 200-300 drug shortages. Three-quarters of the countries said shortages were worse this winter than a year ago. Groups in four countries said that shortages had been linked to deaths.

    It’s a portrait backed by data from regulators. Belgian authorities report nearly 300 medicines in short supply. In Germany that number is 408, while in Austria more than 600 medicines can’t be bought in pharmacies at the moment. Italy’s list is even longer — with over 3,000 drugs included, though many are different formulations of the same medicine.

    Which medicines are affected?

    Antibiotics — particularly amoxicillin, which is used to treat respiratory infections — are in short supply. Other classes of drugs, including cough syrup, children’s paracetamol, and blood pressure medicine, are also scarce.

    Why is this happening?

    It’s a mix of increased demand and reduced supply.

    Seasonal infections — influenza and respiratory syncytial virus (RSV) first and foremost — started early and are stronger than usual. There’s also an unusual outbreak of throat disease Strep A in children. Experts think the unusually high level of disease activity is linked to weaker immune systems that are no longer familiar with the soup of germs surrounding us in daily life, due to lockdowns. This difficult winter, after a couple of quiet years (with the exception of COVID-19), caught drugmakers unprepared.

    Inflation and the energy crisis have also been weighing on pharmaceutical companies, affecting supply.

    Last year, Centrient Pharmaceuticals, a Dutch producer of active pharmaceutical ingredients, said its plant was producing a quarter less output than in 2021 due to high energy costs. In December, InnoGenerics, another manufacturer from the Netherlands, was bailed out by the government after declaring bankruptcy to keep its factory open.

    Commissioner Stella Kyriakides wrote to Greece’s health minister asking him to take into consideration the effects of bans on third countries | Stephanie Lecocq/EPA-EFE

    The result, according to Sandoz, one of the largest producers on the European generics market, is an especially “tight supply situation.” A spokesperson told POLITICO that other culprits include scarcity of raw materials and manufacturing capacity constraints. They added that Sandoz is able to meet demand at the moment, but is “facing challenges.”

    How are governments reacting?

    Some countries are slamming the brakes on exports to protect domestic supplies. In November, Greece’s drugs regulator expanded the list of medicine whose resale to other countries — known as parallel trade — is banned. Romania has temporarily stopped exports of certain antibiotics and kids’ painkillers. Earlier in January, Belgium published a decree that allows the authorities to halt exports in case of a crisis.

    These freezes can have knock-on effects. A letter from European Health Commissioner Stella Kyriakides addressed to Greece’s Health Minister Thanos Plevris asked him to take into consideration the effects of bans on third countries. “Member States must refrain from taking national measures that could affect the EU internal market and prevent access to medicines for those in need in other Member States,” wrote Kyriakides.

    Germany’s government is considering changing the law to ease procurement requirements, which currently force health insurers to buy medicines where they are cheapest, concentrating the supply into the hands of a few of the most price-competitive producers. The new law would have buyers purchase medicines from multiple suppliers, including more expensive ones, to make supply more reliable. The Netherlands recently introduced a law requiring vendors to keep six weeks of stockpiles to bridge shortages, and in Sweden the government is proposing similar rules.

    At a more granular level, a committee led by the EU’s drugs regulator, the European Medicines Agency (EMA), has recommended that rules be loosened to allow pharmacies to dispense pills or medicine doses individually, among other measures. In Germany, the president of the German Medical Association went so far as to call for the creation of informal “flea markets” for medicines, where people could give their unused drugs to patients who needed them. And in France and Germany, pharmacists have started producing their own medicines — though this is unlikely to make a big difference, given the extent of the shortfall.

    Can the EU fix it?

    In theory, the EU should be more ready than ever to tackle a bloc-wide crisis. It has recently upgraded its legislation to deal with health threats, including a lack of pharmaceuticals. The EMA has been given expanded powers to monitor drug shortages. And a whole new body, the Health Emergency Preparedness and Response Authority (HERA) has been set up, with the power to go on the market and purchase drugs for the entire bloc.

    But not everyone agrees that it’s that bad yet.

    Last Thursday, the EMA decided not to ask the Commission to declare the amoxycillin shortage a “major event” — an official label that would have triggered some (limited) EU-wide action— saying that current measures are improving the situation.

    A European Medicines Agency’s working group on shortages could decide on Thursday whether to recommend that the Commission declares the drug shortages a “major event” — an official label that would trigger some (limited) EU-wide action. An EMA steering group for shortages would have the power to request data on drug stocks of the drugs and production capacity from suppliers, and issue recommendations on how to mitigate shortages.

    At an appearance before the European Parliament’s health committee, the Commission’s top health official, Sandra Gallina, said she wanted to “dismiss a bit the idea that there is a huge shortage,” and said that alternative medications are available to use.

    And others believe the situation will get better with time. “I think it will sort itself out, but that depends on the peak of infections,” said Adrian van den Hoven, director general of generics medicines lobby Medicines for Europe. “If we have reached the peak, supply will catch up quickly. If not, probably not a good scenario.”

    Helen Collis and Sarah-Taïssir Bencharif contributed reporting.

    [ad_2]

    Carlo Martuscelli

    Source link

    January 24, 2023
  • Europe’s hot mess response to China’s COVID surge

    Europe’s hot mess response to China’s COVID surge

    [ad_1]

    Press play to listen to this article

    Voiced by artificial intelligence.

    Pandemic politics is back. 

    Three years into the COVID-19 crisis, which upended lives across the globe and led the EU to promise to work better together when the next health crisis emerged, countries have once again been involved in a political tug-of-war.

    China’s decision to lift its zero-COVID policy has led to a surge in cases that has alarmed the world. But early attempts at a joint EU response were dashed when Italy announced its own border control measures on arrivals from China. 

    While the EU is now inching toward a coordinated approach on travel measures for arrivals from China — including pre-departure testing, masks on flights and testing wastewater for possible new variants — and is set to hold a meeting of its crisis response body on Wednesday, it comes after countries one-by-one announced unilateral measures for travelers arriving from China.

    “It is disappointing to me that — despite three years of pandemic — there still is not a coordinated EU united response,” said Marion Koopmans, head of the Erasmus MC’s department of viroscience. 

    So why did European unity fall at the first hurdle? Here’s what you need to know.

    What measures are in place for arrivals from China?

    Here’s a brief rundown of a fast-moving situation. Most countries have announced some form of testing, with Italy testing travelers arriving from China and isolating those that are positive. Spain is testing and carrying out temperature checks, and from Tuesday, imposing COVID certificates, and France requires negative tests before traveling from China, masks on planes and PCR tests on arrival for all passengers.

    Sweden became the latest EU country to announce plans to implement restrictions, saying Tuesday that it was “preparing to introduce travel restrictions requiring a negative COVID-19 test for entry to Sweden from China.” 

    Across the Channel, the U.K. announced Friday it would require a negative test before travel and would also be taking samples from arrivals. 

    Belgium, however, has taken a different tack, testing the wastewater from planes twice a week and sequencing the samples to search for new variants.

    All this could change on Wednesday, however, with the EU’s crisis response body meeting to discuss (finally) a coordinated response.

    A Chinese traveler leaves the arrival hall of Rome Fiumicino airport on December 29, 2022 after being tested for COVID-19 | Filippo Monteforte/AFP via Getty Images

    Why the different responses?

    There are multiple factors at play — bitter experience, fear of new variants, concerns about China’s secrecy, and good old economics.

    Italy, the first to strike out alone, has said its rules will ensure “surveillance and identification of any variants of the virus in order to protect the Italian population.” This decision seems to be driven by the psychology that Italy was hit incredibly hard by COVID-19 in 2020, said Elizabeth Kuiper, associate director and head of the social Europe and well-being program at the European Policy Centre think tank. 

    France has justified its decision by saying the government has taken “health control measures in order to ensure the protection of the French population.” As well as testing, they will also be sequencing positive test results to screen for new variants, according to the prime minister, Elisabeth Borne, potentially belying a mistrust of information coming out of China.

    Over in the U.K., the government has no qualms about saying its decision is due to the “lack of comprehensive health information shared by China.” The health ministry said that if there is an improvement in the sharing of information and greater transparency “then temporary measures will be reviewed.”

    Others have held back. For Austria, which has so far resisted pressure from countries like Italy to coalesce around bloc-wide travel measures, any restriction on China arrivals would be a massive blow. The Austrian government has said that China’s reopening “heralds the return of the most important Asian source market for the coming tourism seasons.” 

    This is “a clear example of how countries are trying to balance the economic consequences of COVID and public health concerns,” said Kuiper. 

    Didn’t EU countries agree to work together? 

    One of Europe’s key lessons from the pandemic was supposed to have been to respond collectively to health threats. It was so important to countries that the EU Health Union was established. But the disagreements over China show that the “default to knee-jerk national responses hasn’t entirely gone away,” said Paul Belcher, consultant in European public health and adviser to the European Public Health Alliance. 

    This disorderly response has raised questions over whether EU coordination has taken the right form. A central part of the EU Health Union is the Health Emergency Preparedness and Response Authority (HERA), which was established precisely to enable Europe to respond quickly and appropriately during a health crisis. But it sits within the European Commission rather than independently — which has tied its hands somewhat, argued the European Policy Centre’s Kuiper.

    “If HERA would have been an independent agency, they could have taken a stronger EU position concerning the need for travel restrictions for passengers coming from China,” Kuiper said. Without this leadership, countries have taken measures based on national motivations, she said. 

    Can we believe Chinese data?

    WHO chief Tedros Adhanom Ghebreyesus said that in order to make a comprehensive risk assessment of the situation on the ground the WHO “needs more detailed information” | Fabrice Coffrini/AFP via Getty Images

    Concerns about China’s transparency on COVID-19 are nothing new but as the country opens its borders, even the World Health Organization, which usually declines to point the finger at specific countries, has called for more information. 

    WHO chief Tedros Adhanom Ghebreyesus has said that in order to make a comprehensive risk assessment of the situation on the ground the WHO “needs more detailed information.”

    What China is doing is sharing genetic sequence data on the international database GISAID, “which is laudable,” said David Heymann, professor of infectious disease epidemiology at the London School of Hygiene and Tropical Medicine. “But they are not sharing the epidemiological data that will help understand the transmissibility and virulence that goes along with each sequence information and thus leaving a gap in our understanding,” he said.

    Meanwhile, China isn’t pleased with the global response. “Some countries have implemented entry restrictions targeting only Chinese travelers. This has no scientific basis, and some practices are unacceptable,” a spokesperson said.

    What does the science say?

    “There is no scientific consensus on what to do, whether it makes sense to test everyone at arrival or not,” said Steven Van Gucht, head of the scientific service of viral diseases at the Belgian national institute for public and animal health. “The current discussion is a mixture of the scientific debate, but it’s also political.”

    One of the major concerns is that new variants could emerge from China. Some scientists say this is unlikely as China is behind the curve on new variants. “Because China’s variants have been and gone in the rest of the world, the threat of these viruses coming back out of China and causing waves is pretty unlikely,” said virologist Tom Peacock of Imperial College, London. Initial sequencing out of Italy has indicated that there were no new COVID variants among Chinese visitors.

    Koopmans said that — based on what has been shared so far — the variants circulating in China are not so different from what’s being seen in other parts of the world, but “there are no reasons to assume they are ‘less fit.’”

    However, if a new variant did emerge, it’s unlikely travel restrictions would completely stop the spread. For Koopmans, travel restrictions “in the past have shown they are not very effective at delaying transmission of variants.”

    One way of quickly spotting the arrival of new variants without targeting individual passengers is to test wastewater from toilets on airplanes or at airports, something that European Health Commissioner Stella Kyriakides has called for — and which is on the table for Wednesday’s meeting.

    Additional reporting from Barbara Moens.

    [ad_2]

    Ashleigh Furlong and Helen Collis

    Source link

    December 19, 2022
  • Treatment Plan for Chronic Spontaneous Urticaria

    Treatment Plan for Chronic Spontaneous Urticaria

    [ad_1]




    Chronic Spontaneous Urticaria Treatment

































    091e9c5e820faac4091e9c5e820faac4FED-Footermodule_FED-Footer_091e9c5e820faac4.xmlwbmd_pb_templatemodule0144002/02/2021 01:57:340HTML















    [ad_2]

    Source link

    October 21, 2022
  • Psoriatic Disease: Why It’s Misunderstood

    Psoriatic Disease: Why It’s Misunderstood

    [ad_1]

    By Diane Talbert, as told to Keri Wiginton

    People often describe psoriasis as raised red patches with white silvery scales. As a person of color, when my psoriasis is active, it’s a thick, purplish hue with scales that crack and bleed. I itch like crazy.

    I also have psoriatic disease that involves my joints. That’s a kind of inflammation that can affect the joints. I get serious fatigue, morning stiffness, swollen fingers and toes, and pain in my tendons.

    So many people have said to me, “You have psoriasis? Isn’t that just dry skin?” With people thinking like this, we will always be misunderstood. By family, friends, and doctors.

    Searching for Answers

    I’m 62 now. Thankfully, I’m on a medication that helps manage my psoriatic disease. But that hasn’t always been the case.

    When I was 5, the staff at my school feared my psoriasis was contagious. They sent me to the hospital on my first day. I had to stay there for 3 months. They had to call in a specialist who finally diagnosed me with psoriasis.

    I don’t think most doctors in 1963 had ever seen a person of color who had more than 80% of their body covered in plaques. And some doctors said I didn’t have this disease because it didn’t look like what they thought psoriasis should look like.

    I learned at a young age that I had to be my own best advocate. I started researching psoriasis as a teenager. To my surprise, I never came across one picture or reference to a Black person with it. Over the next 40 years, I lost count of the doctors who didn’t know how to treat me.

    Skin and Joint Involvement Aren’t Always Linked

    In my 20s, I started getting aches in my joints and my nails started pitting pretty bad. This was painful because my skin would get really thick and lift off the nails. At the time, my doctors said this was due to my psoriasis. But they didn’t test me for joint inflammation.

    One doctor told me I was overreacting, but if the pain was that bad, I should take an aspirin. They said I was too young, even though you could see the swelling in my hands. Instead, they diagnosed me with anxiety and depression.

    After going to numerous doctors, I found a dermatologist who told me to go to a rheumatologist. I finally got a diagnosis of psoriatic disease of my joints at 50 — 25 years after my first symptoms.

    Finding Quality Care

    I started a new biologic medicine at the beginning of the pandemic. But I’ve been on them for 20 years. These are drugs that change how the immune system works. They can slow down the inflammation process, and they work really well for psoriatic disease. But compared to white people, Black people in the U.S. are less likely to get this kind of treatment.

    I believe we, as minorities, struggle so much more with this disease. I’ve spoken with so many people of color who’ve never heard of biologics. I honestly don’t think anyone is going to tell you about them if you don’t have adequate insurance to pay for them. Growing up, I didn’t have great medical coverage, so I didn’t get the best treatment. I also believe that’s why it took me longer to get a proper diagnosis.

    To be honest, I didn’t understand what “disparities in health care” meant when I was younger. But I remember a doctor telling me to add Vaseline to my medication so it would last a whole month. I had scales on 80% of my body, and that’s all he said he could do for me. I spent years taking treatments that didn’t work.

    I think we need to talk about these inequities. Because, speaking from experience, low-income people get different treatment in our medical system. We do get overlooked.

    How to Find the Right Doctor

    If you have psoriatic disease of the joints — or think you do — see a rheumatologist. I’ve had skin involvement for more than 50 years and joint inflammation for 30 years. But I only saw my first rheumatologist about 10 years ago.

    And find a dermatologist who’s familiar with psoriatic disease. The one I have now is very knowledgeable. But many I’ve had in the past haven’t been.

    It’s also helpful that my dermatologist and rheumatologist are on the same page about my treatment plan.

    Before you see your doctor, try to keep a journal of your symptoms. That may help point your doctor in the right direction a little quicker. You’ll want to keep track of things like:

    • Swelling in your fingers or joints
    • Pits in your nails
    • Swelling elsewhere, like your heel
    • How tough it is to get out of bed in the morning
    • How tired you are
    • How often you feel tired

    And when it comes to your doctor, don’t let them shut you down. As I’ve gotten older, I’ve had a chance to look back at how doctors have treated me. They would make decisions and not involve me in my treatment plan. That was a problem for me. I felt like they were telling me to be quiet.

    Here are some other problematic things I’ve heard:

    • The pain is all in your head.              
    • I don’t know what to do to help you.
    • We did all the tests, and we can’t find anything wrong.

    And my all-time favorite, which came from an older rheumatologist: Black people don’t get psoriasis.

    Get Checkups

    My regular doctor knows about my psoriatic disease, but that’s not why I go to her. I know that I need to have regular checkups because of the other conditions that come along with having psoriatic disease. I have:

    • High blood pressure
    • High cholesterol
    • Diabetes

    My doctor and I need to monitor them all.

    Another reason I see my regular doctor is that she might see something that my specialists miss.

    Don’t Give Up

    Make sure you give any new treatment a chance. Even if you’re on the right medicine, it can take a few months for it to work. It’s been trial and error for me with treatments for 50 years. But so much has happened in the medical community during that time, and we have so many effective choices now.

    Diane Talbert, 62, found out she had psoriasis when she was 5. She started having symptoms of joint inflammation in her 20s. She is a blogger, speaker, and advocate for those with psoriatic disease and other chronic diseases. She founded “Power Beyond Psoriasis,” a nonprofit group. Her No. 1 supporter is her husband, Alvin.

    [ad_2]

    Source link

    October 10, 2022

ReportWire

Breaking News & Top Current Stories – Latest US News and News from Around the World

  • Blog
  • About
  • FAQs
  • Authors
  • Events
  • Shop
  • Patterns
  • Themes

Twenty Twenty-Five

Designed with WordPress